Brainstorm Cell Therapeutics Inc
NASDAQ:BCLI
Brainstorm Cell Therapeutics Inc
NASDAQ:BCLI
Price:
0.433 USD
5.33%
Market Closed
Updated:
Jun 11, 2024
Brainstorm Cell Therapeutics Inc
Free Cash Flow
|
Brainstorm Cell Therapeutics Inc
Free Cash Flow Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Brainstorm Cell Therapeutics Inc
NASDAQ:BCLI
|
Free Cash Flow
-$19.5m
|
CAGR 3-Years
13%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-17%
|
|
|
Abbvie Inc
NYSE:ABBV
|
Free Cash Flow
$21.9B
|
CAGR 3-Years
7%
|
CAGR 5-Years
11%
|
CAGR 10-Years
16%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Free Cash Flow
$7.9B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
3%
|
CAGR 10-Years
8%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Free Cash Flow
$7.1B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
2%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Free Cash Flow
$3.5B
|
CAGR 3-Years
5%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Free Cash Flow
$3.9B
|
CAGR 3-Years
25%
|
CAGR 5-Years
13%
|
CAGR 10-Years
27%
|
See Also
What is Brainstorm Cell Therapeutics Inc's Free Cash Flow?
Free Cash Flow
-19.5m
USD
-19.5m
USD
Based on the financial report for Mar 31, 2024, Brainstorm Cell Therapeutics Inc's Free Cash Flow amounts to -19.5m USD.
What is Brainstorm Cell Therapeutics Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
-17%
-17%
Over the last year, the Free Cash Flow growth was 1%. The average annual Free Cash Flow growth rates for Brainstorm Cell Therapeutics Inc have been 13% over the past three years , -11% over the past five years , and -17% over the past ten years .
You don't have any saved screeners yet
